These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38901787)

  • 1. Diabetes and brain disorders, a new role for insulin?
    de Galan BE
    Neurosci Biobehav Rev; 2024 Aug; 163():105775. PubMed ID: 38901787
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin and neurodegenerative disease: shared and specific mechanisms.
    Craft S; Watson GS
    Lancet Neurol; 2004 Mar; 3(3):169-78. PubMed ID: 14980532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does insulin dysfunction play a role in Alzheimer's disease?
    Gasparini L; Netzer WJ; Greengard P; Xu H
    Trends Pharmacol Sci; 2002 Jun; 23(6):288-93. PubMed ID: 12084635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking insulin with Alzheimer's disease: emergence as type III diabetes.
    Ahmed S; Mahmood Z; Zahid S
    Neurol Sci; 2015 Oct; 36(10):1763-9. PubMed ID: 26248483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain insulin resistance may exacerbate Alzheimer's progression. Researchers call it "Type III" diabetes.
    Duke Med Health News; 2012 Sep; 18(9):4-5. PubMed ID: 23029691
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
    Nguyen TT; Ta QTH; Nguyen TKO; Nguyen TTD; Giau VV
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin, diabetes mellitus, Alzheimer's disease, and apolipoprotein E.
    Gambassi G; Bernabei R
    Neurology; 1998 Sep; 51(3):925-6. PubMed ID: 9748080
    [No Abstract]   [Full Text] [Related]  

  • 8. New type of diabetes linked to Alzheimer's disease. Reduced levels of insulin produced in brain can lead to death of key brain cells.
    Health News; 2005 Jul; 11(7):8-9. PubMed ID: 16050025
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
    Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain damage in a juvenile diabetic patient associated with insulin hypoglycemia.
    GARDNER LI; REYERSBACH GC
    Pediatrics; 1951 Feb; 7(2):210-4. PubMed ID: 14827625
    [No Abstract]   [Full Text] [Related]  

  • 11. Extending Arms of Insulin Resistance from Diabetes to Alzheimer's Disease: Identification of Potential Therapeutic Targets.
    Gupta S; Singhal NK; Ganesh S; Sandhir R
    CNS Neurol Disord Drug Targets; 2019; 18(3):172-184. PubMed ID: 30430949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent.
    Faiq MA; Dada T
    Curr Mol Med; 2017; 17(1):46-59. PubMed ID: 28176628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.
    de la Monte SM; Wands JR
    J Alzheimers Dis; 2005 Feb; 7(1):45-61. PubMed ID: 15750214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes drugs and neurological disorders: new views and therapeutic possibilities.
    Patrone C; Eriksson O; Lindholm D
    Lancet Diabetes Endocrinol; 2014 Mar; 2(3):256-62. PubMed ID: 24622756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface.
    Biessels GJ; Bravenboer B; Gispen WH
    Eur J Pharmacol; 2004 Apr; 490(1-3):1-4. PubMed ID: 15094068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links.
    Pakdin M; Toutounchian S; Namazi S; Arabpour Z; Pouladi A; Afsahi S; Poudineh M; Nasab MMM; Yaghoobpoor S; Deravi N
    Curr Diabetes Rev; 2022; 18(8):e051121197760. PubMed ID: 34749616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
    Ribe EM; Lovestone S
    J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.
    Ghasemi R; Dargahi L; Haeri A; Moosavi M; Mohamed Z; Ahmadiani A
    Mol Neurobiol; 2013 Jun; 47(3):1045-65. PubMed ID: 23335160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between dysglycemia and cognitive dysfunction.
    Cukierman-Yaffee T
    Curr Opin Investig Drugs; 2009 Jan; 10(1):70-4. PubMed ID: 19127489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.